MedPath

Gary Morrow

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

16

Active:0
Completed:15

Trial Phases

3 Phases

Phase 2:4
Phase 3:6
Not Applicable:6

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials

Not Applicable
6 (37.5%)
Phase 3
6 (37.5%)
Phase 2
4 (25.0%)

Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer

Phase 2
Completed
Conditions
Breast Carcinoma
Stage 0 Breast Cancer
Pain
Radiation-Induced Dermatitis
Interventions
Drug: Curcumin-based Gel
Procedure: Dermatologic Complications Management
Other: Laboratory Biomarker Analysis
Other: Placebo
Other: Questionnaire Administration
First Posted Date
2015-09-22
Last Posted Date
2017-11-06
Lead Sponsor
Gary Morrow
Target Recruit Count
191
Registration Number
NCT02556632
Locations
🇺🇸

Delaware/Christiana Care NCORP, Newark, Delaware, United States

🇺🇸

Heartland NCORP, Decatur, Illinois, United States

🇺🇸

Metro-Minnesota NCORP, Minneapolis, Minnesota, United States

and more 3 locations

Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors

Not Applicable
Completed
Conditions
Cancer
Breast Carcinoma
Fatigue
First Posted Date
2015-02-02
Last Posted Date
2017-08-08
Lead Sponsor
Gary Morrow
Target Recruit Count
108
Registration Number
NCT02352779
Locations
🇺🇸

Wichita NCORP, Wichita, Kansas, United States

🇺🇸

Cancer Research Consortium of West Michigan, Grand Rapids, Michigan, United States

🇺🇸

University of Rochester NCORP Research Base, Rochester, New York, United States

and more 3 locations

Multimedia Psychoeducation or Print Education in Preparing Cancer Patients for Decision Making About Clinical Trials

Not Applicable
Completed
Conditions
Malignant Neoplasm
First Posted Date
2014-02-04
Last Posted Date
2021-01-27
Lead Sponsor
Gary Morrow
Target Recruit Count
418
Registration Number
NCT02054715
Locations
🇺🇸

San Diego State University, San Diego, California, United States

🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

🇺🇸

Hawaii MU-NCORP, Honolulu, Hawaii, United States

and more 15 locations

Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

Not Applicable
Completed
Conditions
Stage IA Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer
Stage IIIC Breast Cancer
Stage IIIB Breast Cancer
Sleep Disorder
Stage IB Breast Cancer
First Posted Date
2013-12-06
Last Posted Date
2019-06-05
Lead Sponsor
Gary Morrow
Target Recruit Count
71
Registration Number
NCT02002533
Locations
🇺🇸

Stanford University Medical Center, Stanford, California, United States

🇺🇸

Heartland NCORP, Decatur, Illinois, United States

🇺🇸

Wichita NCORP, Wichita, Kansas, United States

and more 3 locations

Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy

Not Applicable
Completed
Conditions
Fatigue
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2009-06-19
Last Posted Date
2017-08-08
Lead Sponsor
Gary Morrow
Target Recruit Count
693
Registration Number
NCT00924651
Locations
🇺🇸

James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.